Who invested in Shennon Biotechnologies

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$25Mraised across 2 rounds since 2023, from 2 sources

$13MSeed$12MVenture

Latest round: Venture, $12MSept 2026
Biggest round: $13MSeed · Mar 2023
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2023202420252026

$13MSeed$12MVenture

First round: Seed, $13M
Biggest round: $13M
Between rounds: 3.5 years

The rounds

Sept 2026
Venture$12M1 new2 returning
Source recorded
Mar 2023
Seed$13M2 new
- Foundation Capital
- DCVC
Source recordedSEC filing: $7.3M sold, first sale Dec 2022

Founders and team

From Shennon Biotechnologies's own website and the SEC filings it signed: 9 on the team.

Chad PutnamFractional Chief Financial Officer
Full TimeCSO / VP of R&D
Formerly St. Jude HospitalAssociate Professor of Dermatology in Microbiology and Immunology
Jacqueline TaitBusiness Analyst
Lauren HunterPlatform Engineer
Naomi PtakOperations Manager
Sonali KanayaSenior Research Associate
Weill Cornell MedicineAssociate Professor of Dermatology in Microbiology and Immunology
Li SunExecutive Officer, Directori

On the board, as filediJames Hardiman

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2023Venture2026

Foundation Capital

DCVC

Future Ventures

Everyone who backed them

Foundation CapitalVC firm2rounds

DCVCVC firm2rounds

Future VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Shennon Biotechnologies as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.